ADXN.SW
Price:
$0.043
Market Cap:
$6.53M
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established ...[Read more]
Industry
Biotechnology
IPO Date
2007-05-22
Stock Exchange
SIX
Ticker
ADXN.SW
According to Addex Therapeutics Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 5.70M. This represents a change of 8.52% compared to the average of 5.25M of the last 4 quarters.
The mean historical Enterprise Value of Addex Therapeutics Ltd over the last ten years is 12.58M. The current 5.70M Enterprise Value has changed 4.43% with respect to the historical average. Over the past ten years (40 quarters), ADXN.SW's Enterprise Value was at its highest in in the March 2019 quarter at 85.41M. The Enterprise Value was at its lowest in in the September 2022 quarter at -3056358.63.
Average
12.58M
Median
11.99M
Minimum
-2038353.58
Maximum
34.97M
Discovering the peaks and valleys of Addex Therapeutics Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 184.31%
Maximum Annual Enterprise Value = 34.97M
Minimum Annual Increase = -2345.10%
Minimum Annual Enterprise Value = -2038353.58
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 4.61M | 99.33% |
| 2024 | 2.31M | -2345.10% |
| 2023 | -102993.79 | -94.95% |
| 2022 | -2038353.58 | -113.17% |
| 2021 | 15.48M | -55.73% |
| 2020 | 34.97M | 184.31% |
| 2019 | 12.30M | 5.38% |
| 2018 | 11.67M | -56.85% |
| 2017 | 27.05M | 38.11% |
| 2016 | 19.58M | -30.79% |
The current Enterprise Value of Addex Therapeutics Ltd (ADXN.SW) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
2.27M
5-year avg
4.05M
10-year avg
12.58M
Addex Therapeutics Ltd’s Enterprise Value is less than Santhera Pharmaceuticals Holding AG (301.06M), less than Newron Pharmaceuticals S.p.A. (291.87M), less than Basilea Pharmaceutica AG (736.58M), less than EvoNext Holdings S.A. (10.33M), less than Cosmo Pharmaceuticals N.V. (1.14B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 301.06M | $225.73M | |
| 291.87M | $245.51M | |
| 736.58M | $677.00M | |
| 10.33M | $15.94M | |
| 1.14B | $1.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Addex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Addex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Addex Therapeutics Ltd's Enterprise Value?
What is the highest Enterprise Value for Addex Therapeutics Ltd (ADXN.SW)?
What is the 3-year average Enterprise Value for Addex Therapeutics Ltd (ADXN.SW)?
What is the 5-year average Enterprise Value for Addex Therapeutics Ltd (ADXN.SW)?
How does the current Enterprise Value for Addex Therapeutics Ltd (ADXN.SW) compare to its historical average?